Parity, infertility, oral contraceptives, and HRT and the risk of ovarian serous borderline tumors

abstract:
Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study

 Highlights

•

Parity and use of oral contraceptives are both highly protective factors in development of an ovarian serous borderline tumor

•

Infertility and use of hormone replacement therapy are risk factors for developing an ovarian serous borderline tumor

•

An ovarian serous borderline tumor and serous ovarian cancer seem to share some similar risk factors